Sponsor
Inhatarget Therapeutics
Rue Antoine De Saint-Exupery 2, 6041 Charleroi, Belgium
About the sponsor
Inhatarget Therapeutics focuses on oncology research centered on non-small cell lung cancer, with interest in advanced disease settings and treatments designed for patients with stage IV disease. Its clinical activity reflects a targeted effort in lung cancer care, particularly where new therapeutic options are needed alongside existing treatment approaches.
- Advanced NSCLC
- Stage IV lung cancer
- Inhaled therapies
- Add-on treatment strategies
The sponsor’s research activity is concentrated in respiratory oncology, with clinical interest in treatment concepts that address tumor involvement in the lungs through localized delivery approaches.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.